Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

H2020-FTIPilot-2015-1-Chitosán: Nueva solución para aplicaciones biomédicas y biofarmacéuticas. Búsqueda de socios industriales

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDES20150918001
Publicado:
21/09/2015
Resumen:
Un empresa española de biotecnología médica busca socios con el fin de presentar una propuesta a la próxima convocatoria de la acción piloto "Fast Track to Innovation". El objetivo es desarrollar una nueva metodología de producción, extracción, purificación y aplicación de quitina de alta calidad para uso biomédico y farmacéutico. La quitina es una molécula que se utiliza en aplicaciones biomédicas y farmacéuticas por sus propiedades antivirales, antitumorales, bacteriostáticas, fungistáticas, anticoagulantes, cicatrizantes, contra el colesterol y antiuricémicas. Se buscan socios industriales especializados en marketing y análisis en el campo de dispositivos médicos o quirúrgicos.


Details

Tittle:
H2020-FTIPilot-2015-1-Chitosan: A new solution for biomedical and biopharmaceuticals applications- looking for industrial partners
Summary:
A Spanish medical biotechnology company is looking for partners in order to submit a proposal to the next Fast Track to Innovation Pilot call. The aim of the project is to develop an innovative methodology of production, extraction, purification and application of high quality chitin for biomedical and pharmaceutical use. Industrial partners specialized in marketing development and analysis in the field of medical or surgical devices are sought.
Description:
Chitin is a widely known molecule used in biomedical and pharmaceutical applications due to its antiviral, antitumor, bacteriostatic, fungistatic, anticoagulant, healing, anti-choloesterol and antiuricémic, properties. However the quality, purity and extraction methods are not ideal. The Spanish medical biotechnology company is preparing a project proposal with the aim of developing an innovative methodology of production, extraction, purification and application of high quality chitin for biomedical and pharmaceutical use.

The Spanish company currently has a breeding center of chitin rich insects, and a method for extraction the molecule is being developed and validated, which is the step that must be improved to optimize and obtain a high quality and purity chitin. Once obtained, this chitin will be employed in the manufacture of creams and wounds healing burns and ulcers, antimicrobial and antiseptic surgery material, drug diluents through controlled distribution in the body, creating materials for orthopedics, etc. The Spanish company will prepare and test the efficacy of healing creams, cholesterol-lowering action by preclinical models.

The consortium is now made of two partners from Spain and one of Czech Republic. In order to complete the consortium, industrial partners (SMEs and/or large companies) with experience in marketing analysis are sought. Preferably, these partners should come from any European country different from Spain and Czech Republic, and their activity should be related to the distribution of surgical and medical devices.

Call deadline: December 1st, 2015.
Expressions of interests deadline: November 1st, 2015
IPR Status:
Secret know-how

Partner sought

Partner Sought:
SMEs and/or large companies willing to collaborate in the tasks related to marketing development and market analysis, including the creation of a potential client portfolio, are sought. Specifically, the potential partners should have experience in distributing medical or surgical devices.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
Spanish

Dissemination

Restrict dissemination to specific countries:
Austria
Belgium
Croatia
Cyprus
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Sweden
United Kingdom

Programme-call

Evaluation Scheme:
Single stage submission scheme
Coordinator Required:
No
Deadline for Call:
01/12/2015
Project Duration:
0